Bio-Path Holdings, Inc.

BPTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-6.8M $-5.5M $-4.5M $-3.3M $-2.6M $-2.4M $-2.1M
Depreciation & Amortization — — — — — — —
Depreciation $43.0K $41.0K $10.0K $0 $0 — —
Amortization — — $1.2M $1.1M $928.2K $791.5K —
Stock-Based Compensation $784.0K $369.0K $404.0K $704.5K $63.4K $382.9K $477.4K
Net Cash from Operating Activities $-8.1M $-5.0M $-3.8M $-2.3M $-2.0M $-1.1M $-1.1M
Investing Activities
Capital Expenditures $338.0K $0 $123.0K $0 $0 — —
Business Acquisitions — — — — — — —
Net Cash from Investing Activities $-338.0K — — $0 $-25.0K $-170.1K $-229.7K
Financing Activities
Dividends Paid — — — — — — —
Stock Repurchases — — — — — — —
Net Cash from Financing Activities $9.0M — — $5.3M $1.6M $2.0M $1.0M
Net Change in Cash — — — — — — —
Free Cash Flow $-8.5M $-5.0M $-3.9M $-2.3M $-2.0M — —
← Newer Page 2 of 2 Older →